Schaumburg, Illinois Sep 28, 2023 (Issuewire.com) - The American Medical Women's Association (AMWA) announces 66 women physicians honored with the 2023 AMWA INSPIRE Award. This annual award celebrates the accomplished
Wake Forest School of Medicine and the American Federation for Aging Research have received a renewal award for up to $5 million over five years from the National Institute on Aging, National Institutes of Health, to continue their management of the Research Centers Collaborative Network.
FDA approves drug to reduce frequency of chemotherapy-induced bone marrow suppression
Today, the U.S. Food and Drug Administration approved Cosela (trilaciclib) as the first therapy in its class to reduce the frequency of chemotherapy-induced bone marrow suppression in adults receiving certain types of chemotherapy for extensive-stage (when the cancer has spread beyond the lungs) small cell lung cancer. Cosela may help protect bone marrow cells from damage caused by chemotherapy by inhibiting cyclin- dependent kinase 4/6, a type of enzyme.
For patients with extensive-stage small cell lung cancer, protecting bone marrow function may help make their chemotherapy safer and allow them to complete their course of treatment on time and according to plan. Today s approval of Cosela will give patients a treatment option that can reduce the occurrence of a common, harmful side effect of chemotherapy.